EPCAM and hepatocellular carcinoma: In vitro knockdown of linc00152 in HCC cells decreases the promoter activity of EpCAM, and increases expression of E-cadherin while suppressing N-cadherin to successfully decrease the proliferative and migratory capacity of HCC cells (9, 10).